Vident Advisory, LLC
Institutional investor · Portfolio as of Q3 2023
Top Holdings1,252 positions
Alphabet Inc | 486,451 | $63.7M | 2.0% | $129.63 | 0.00% | 1 qtr | First report 0 |
UnitedHealth Group Inc | 101,588 | $51.2M | 1.6% | $473.48 | 0.00% | 1 qtr | First report 0 |
Cisco Systems Inc/Delaware | 823,697 | $44.3M | 1.4% | $49.67 | 0.00% | 1 qtr | First report 0 |
Broadcom Inc | 52,012 | $43.2M | 1.3% | $80.41 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 255,524 | $39.8M | 1.2% | $143.02 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp | 122,627 | $38.7M | 1.2% | $308.52 | 0.00% | 1 qtr | First report 0 |
Home Depot Inc/The | 127,738 | $38.6M | 1.2% | $279.77 | 0.00% | 1 qtr | First report 0 |
AbbVie Inc | 244,856 | $36.5M | 1.1% | $134.39 | 0.00% | 1 qtr | First report 0 |
Apple Inc | 196,908 | $33.7M | 1.0% | $168.93 | 0.00% | 1 qtr | First report 0 |
Danaher Corp | 128,092 | $31.8M | 1.0% | $215.85 | 0.00% | 1 qtr | First report 0 |
ETF SER SOLUTIONS | 617,212 | $28.9M | 0.9% | $45.81 | 0.00% | 1 qtr | First report 0 |
Bristol-Myers Squibb Co | 494,097 | $28.7M | 0.9% | $50.40 | 0.00% | 1 qtr | First report 0 |
Comcast Corp | 617,044 | $27.4M | 0.8% | $36.66 | 0.00% | 1 qtr | First report 0 |
T-Mobile US Inc | 186,487 | $26.1M | 0.8% | $133.16 | 0.00% | 1 qtr | First report 0 |
Altria Group Inc | 550,305 | $23.1M | 0.7% | $33.67 | 0.00% | 1 qtr | First report 0 |
CVS Health Corp | 323,595 | $22.6M | 0.7% | $62.27 | 0.00% | 1 qtr | First report 0 |
Applied Materials Inc | 163,152 | $22.6M | 0.7% | $135.39 | 0.00% | 1 qtr | First report 0 |
VANGUARD S&P500 INDEX ETF | 56,277 | $22.1M | 0.7% | $378.04 | 0.00% | 1 qtr | First report 0 |
Cameco Corp | 553,238 | $21.9M | 0.7% | $39.41 | 0.00% | 1 qtr | First report 0 |
Amgen Inc | 80,193 | $21.6M | 0.7% | $245.66 | 0.00% | 1 qtr | First report 0 |
Vident Advisory, LLC manages $3.2B across 1252 positions as of Q3 2023. Top holdings: GOOGL (2.0%), UNH (1.6%), CSCO (1.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
First quarter we have for this fund: 1252 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $3.2B across 1252 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR